These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2568596

  • 1. Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor.
    O'Boyle KM, Gaitanopoulos DE, Brenner M, Waddington JL.
    Neuropharmacology; 1989 Apr; 28(4):401-5. PubMed ID: 2568596
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J, Hyttel J, Perregaard J.
    Eur J Pharmacol; 1987 Jan 13; 133(2):137-45. PubMed ID: 2949991
    [Abstract] [Full Text] [Related]

  • 3. Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro.
    Arnt J, Hyttel J, Sánchez C.
    Eur J Pharmacol; 1992 Mar 24; 213(2):259-67. PubMed ID: 1355737
    [Abstract] [Full Text] [Related]

  • 4. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
    Murray AM, Waddington JL.
    Eur J Pharmacol; 1989 Feb 07; 160(3):377-84. PubMed ID: 2565818
    [Abstract] [Full Text] [Related]

  • 5. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
    O'Boyle KM, Waddington JL.
    Neuropharmacology; 1992 Feb 07; 31(2):177-83. PubMed ID: 1532443
    [Abstract] [Full Text] [Related]

  • 6. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy.
    Andersen PH, Jansen JA.
    Eur J Pharmacol; 1990 Jun 12; 188(6):335-47. PubMed ID: 1973652
    [Abstract] [Full Text] [Related]

  • 7. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
    Hasegawa M, Adachi K, Nakamura S, Sato M, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 2001 Jul 06; 423(2-3):171-8. PubMed ID: 11448482
    [Abstract] [Full Text] [Related]

  • 8. New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
    Murray AM, Waddington JL.
    Pharmacol Biochem Behav; 1990 Jan 06; 35(1):105-10. PubMed ID: 1969161
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour.
    Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.
    Biochem Pharmacol; 1995 May 11; 49(9):1185-93. PubMed ID: 7763300
    [Abstract] [Full Text] [Related]

  • 10. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH, Kline RH, Geter-Douglass B, Izenwasser S, Witkin JM, Newman AH.
    J Med Chem; 1996 Aug 16; 39(17):3423-8. PubMed ID: 8765528
    [Abstract] [Full Text] [Related]

  • 11. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
    Flaim KE, Gessner GW, Crooke ST, Heys JR, Weinstock J.
    Life Sci; 1986 Jun 09; 38(23):2087-96. PubMed ID: 2872567
    [Abstract] [Full Text] [Related]

  • 12. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S, Lee J, Kiguchi M, Uchida T, Cools AR, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 2006 May 24; 538(1-3):94-100. PubMed ID: 16682023
    [Abstract] [Full Text] [Related]

  • 13. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ, Mulder AH, Schoffelmeer AN.
    J Neurochem; 1990 Oct 24; 55(4):1274-80. PubMed ID: 2168934
    [Abstract] [Full Text] [Related]

  • 14. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ, Roth BL, Kinsella A, Waddington JL.
    Eur J Pharmacol; 2004 Feb 23; 486(3):273-80. PubMed ID: 14985049
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM, Waddington JL.
    Br J Pharmacol; 1995 Oct 23; 116(3):2120-6. PubMed ID: 8640354
    [Abstract] [Full Text] [Related]

  • 16. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
    Barnett A, Ahn HS, Billard W, Gold EH, Kohli JD, Glock D, Goldberg LI.
    Eur J Pharmacol; 1986 Sep 09; 128(3):249-53. PubMed ID: 2878816
    [Abstract] [Full Text] [Related]

  • 17. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 18. Specific D1 and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat.
    Rouillard C, Bédard PJ.
    Neuropharmacology; 1988 Dec 02; 27(12):1257-64. PubMed ID: 2907616
    [Abstract] [Full Text] [Related]

  • 19. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT, Headley PM.
    Eur J Pharmacol; 1986 Jun 05; 125(1):79-83. PubMed ID: 3015643
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 05; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.